Skip to content
Research Article Open access CC BY 4.0

Antibiogram of Pseudomonas aeruginosa Clinical Isolates Tested for Pan, Extensive and Multidrug Resistances

Uzoamaka Maduakor, Clara Eleazar, Chidozie Nwafor, Veronica Emenuga

Microbiology Research Journal International · pp. 14–21 · Published 30 Dec 2023

10.9734/mrji/2023/v33i11-121413

Abstract

Background: Pseudomonas aeruginosa usually cause nosocomial infections with concurrent morbidity and mortality and is generally resistant to many antibiotics. Aim: This study was aimed to determine the proportion of pan-drug-resistant (PDR), extensively drug-resistant (XDR), and multidrug-resistant (MDR) P. aeruginosa strains recovered from human samples. Methodology: The retrospective study was conducted in the University of Nigeria Teaching Hospital Enugu in 2023. Clinical samples obtained from patients between October 2022 and April 2023 were analysed. A total of 100 Pseudomonas aeruginosa isolates recovered from 780 clinical samples were used. Standard microbiological techniques were used to identify and categorize the isolates. Antibiotic susceptibility pattern was determined using the Kirby Bauer disc diffusion method. Results:  Isolates recovered from wound was 38%, voided urine, catheter tip urine, ear swab, and high vaginal swab samples recorded 29%, 11%, 10% and 4%, respectively. Ceftazidime recorded the highest level of resistance (70.0%) and the least was Colistin (20%). Resistance patterns showed that 32(32.0%) bacterial strains were MDR,   68(68.0%) were XDR and no PDR was recorded. Conclusions: For the best selection of empirical therapy, P. aeruginosa susceptibility monitoring is essential due to the high prevalence of antibiotic resistance. The resistance pattern raises the possibility of misuse of broad-spectrum antibiotics. Treatment for bacterial infections should be directed by the results of antimicrobial susceptibility tests.

Pseudomonas aeruginosa antibiotic nosocomial resistance infections

References (12)

  1. 1 Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies [DOI]
  2. 2 Pseudomonas aeruginosa: all roads lead to resistance [DOI]
  3. 3 WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
  4. 4 Mechanisms of antimicrobial resistance in bacteria [DOI]
  5. 5 Antimicrobial resistance of Pseudomonas aeruginosa biofilms [DOI]
  6. 6 Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment [DOI]
  7. 7 High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico [DOI]
  8. 8 Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosapneumonia [DOI]
  9. 9 Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009) [DOI]
  10. 10 Pathogen burden & associated antibiogram of Pseudomonas spp. in a tertiary care hospital of India [DOI]
  11. 11 Increasing incidence of multidrug resistant Pseudomonas aeruginosa in inpatients of a tertiary care hospital [DOI]
  12. 12 Occurrence of Multiple, Extensive and Pan Drug-Resistant Pseudomonas aeruginosa and Carbapenemase Production from Presumptive Isolates Stored in a Biobank at Ethiopian Public Health Institute [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

19

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.